axogen

Registration is open! Axogen is hosting an ASSH pre-course with advanced hands-on and didactic sessions for treating peripheral nerve injuries. Join us Wednesday, September 18, 2024, 8am – 4pm. Email [email protected] for more information or to save your spot today!

Axogen's microsurgical trainer will be on hand in booth 7 at FESSH to help enhance your skills. To schedule an appointment, book here https://hubs.la/Q02Bpp9W0

All sessions are hosted on Zoom 8:30-9:30pm EST. Session schedule: June 26: Complex traumatic nerve injuries July 9: Surgical management of pain July 22: Optimizing sensorimotor nerve injury outcomes Aug 5: Becoming “The Nerve Surgeon” or Building a Peripheral Nerve Clinic Aug 20: Lower extremity restoration and collaboration Sept 9: Augmenting my nerve repair Sept 19: Live at ASSH: Practice management and economics Get in touch with us today to learn more about this customizable program. Email [email protected] or reach out to your local Axogen representative.

Nerve regeneration isn't all about the axons. This enthralling work, published recently in Neuron, shows how important angiogenesis is in the early days post-injury and how signaling molecules that control vascular patterning in early development come back to life after injury. Visit the link to learn more, https://hubs.ly/Q02wfzbf0 These links will navigate you away from Axogen’s website. Links outside Axogen’s website are provided as a resource to the viewer. Axogen accepts no responsibility for or control over the content of the linked sites.

We are excited to attend FESSH June 26-29th in Rotterdam, Netherlands. Come talk to our experts at booth 07 to learn about our full-body peripheral nerve repair technologies and receive hands-on micro training!

Resection of the mandible can be necessary for either benign or malignant pathologies. Dental implants and reconstruction of the mandible and surrounding soft tissues restore function and form. The transected nerve, however, may be left untreated. This new paper shows that nerve repair using an allograft resulted in fewer mandibular resection patients with chronic postsurgical pain and neuropathic pain compared to the control group whose nerves were not repaired. There is a growing need for more quality-of-life studies in mandibular reconstruction patients and this paper is an important step in that direction. Click here to read more; https://hubs.la/Q02wfftw0 These links will navigate you away from Axogen’s website. Links outside Axogen’s website are provided as a resource to the viewer. Axogen accepts no responsibility for or control over the content of the linked sites.

Left untreated, even non-transected nerve injuries can lead to persistent pain, #neuromas, decreased mobility or even sensation loss. Nerve protection helps combat nerve tethering and may reduce the risk of future nerve compression, decreased nerve gliding and incomplete recovery. Learn how to incorporate nerve protection into your procedures at https://hubs.la/Q02wfmJ90 #NerveDamage #NerveRepair #NerveProtection

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft® https://lnkd.in/e5mQbaDc

Congratulations to all of the newly matched fellows. We wish you the best as you begin your fellowship! #Axogen

Dr. Kyle Eberlin says the topic of symptomatic neuromas is near and dear to his heart – and it shows in this review article! From neuropeptides to ion channels to surgical interventions, this review provides a detailed analysis of the "Biology and Pathophysiology of Symptomatic Neuromas" that you will not get anywhere else. Kudos to all the authors! Click here to read more; https://hubs.la/Q02wfbZr0 These links will navigate you away from Axogen’s website. Links outside Axogen’s website are provided as a resource to the viewer. Axogen accepts no responsibility for or control over the content of the linked sites.